NEWS AND EVENTS

Stay updated with the latest news and events from the INJECTHEAL project. Here you will find announcements, progress updates, scientific publications, and details about conferences, workshops, and other activities involving our consortium. Follow this page to keep track of our milestones and upcoming opportunities to engage with the project.

“HEALing begins here: INJECTHEAL round table discussion on chronic wounds and patient-centered innovation”will take place on 26 September 2025 in Novara.

Novara, 22/09/2025 – On Friday, September 26, 2025, from 11 a.m. to 12 p.m., the “G. Cattaneo” Auditorium (via Perrone 18, Novara) will host a public round table titled “HEALing Starts Here: INJECTHEAL Roundtable on Chronic Wounds and Patient-Centered Innovation.” The roundtable has been organised in the framework of the “First Consortium Meeting” of the INJECTHEAL project, coordinated by Professor Lia Rimondini, Head of the Department of Health Sciences of the University of Eastern Piedmont.

The event will be attended by researchers, experts, and representatives of Italian and foreign institutions benefiting from the INJECTHEAL project, to discuss the research topic covered by the project, namely the development of new therapeutic approaches for the treatment of chronic wounds. Chronic wounds are still a significant clinical condition and affect a large percentage of the world’s population (over 1%). This condition has a major impact on patients’ quality of life and entails significant costs for healthcare systems.

Chronic wounds remain an ongoing challenge for medicine, as current treatment practices have significant limitations in terms of effectiveness, particularly in relation to controlling infections and inflammation and supporting tissue regeneration.

The aim of the INJECTHEAL project is to provide a concrete response to these shortcomings by developing a 4D injectable hydrogel designed for the targeted release of active ingredients into complex wounds and to support tissue regeneration processes, contributing to the reduction of inflammatory and infectious processes. The hydrogel will be developed using sustainable materials, with the aim of offering an advanced therapeutic option, particularly for “deep tunnel” wounds.

The round table will feature:

Menico Rizzi, Rector of the University of Piedmont

Ellie Lindsay, Officer of the Order of the British Empire, Honorary Professor, The College of Phlebology, London

Matteo Santin, Professor of Tissue Regeneration at the University of Brighton, UK

Mohammad Raoufi: Associate Senior Scientist at the University of Siegen, entrepreneur, and recognized expert in the field of CW

Elham Sharifikolouei, Researcher at the Department of Health Sciences at University of Eastern Piedmont

Lia Rimondini, Director of DISS and coordinator of INJECTHEAL.

The event will be held in English and is open to the public.

OUR PARTNERS

Universities:

Research Centres:

SMEs:

Charities:

Download the press release in English at this link 

Download the press release in Italia at this link

INJECTHEAL First Consortium Meeting | 25th -26th September, 2025

The first INJECTHEAL Consortium Meeting, organised by the University of Piemonte Orientale “Amedeo Avogadro”, will take place in Novara, Italy, on 25–26 September 2025. 

This event will give partners the chance to meet in person for the first time to discuss project progress.

Participants will also be given a tour of the project coordinator’s laboratories and research facilities.

Download the draft agenda

The European Commission awards the INJECTHEAL project: a research project dedicated to the development of new solutions for the treatment of chronic wounds

Novara 03 June 2025

The Università del Piemonte Orientale announces the official start of INJECTHEAL, a research project dedicated the development of new solutions for the treatment of chronic wounds, coordinated by Professor Lia Rimondini, head of the Department of Health Sciences.

INJECTHEAL was awarded a grant of about EUR 7.3 million under the Horizon Europe programme, with a total project cost of more than EUR 7.9 million. The planned duration of the project is three years, from 1 May 2025 to 30 April 2028.

Chronic wounds represent a significant clinical condition, affecting a large percentage of the population. These conditions can affect patients’ quality of life and incur significant costs to healthcare systems. Current therapeutic strategies have limitations in treating deep wounds, controlling infection and inflammation, and supporting tissue regeneration.

At the heart of the project is the development of a 4D injectable hydrogel, designed for the targeted release of healing properties into complex wounds and to support tissue regeneration processes, contributing to the reduction of inflammatory and infectious processes. The hydrogel will be developed using sustainable materials, with the goal of providing an advanced therapeutic option, particularly for “deep tunnelling” wounds.

‘The coordination of INJECTHEAL represents a significant commitment for our University in the field of transnational research’ said Prof. Lia Rimondini. ‘The aim of the project is to develop a therapeutic approach that can improve the management of chronic wounds. We will work in close collaboration with doctors and patients, with a focus on their opinions and needs. This will allow us to develop a solution that is really useful and easy to use in everyday practice’.

The consortium of INJECTHEAL consists of 13 partners from 8 European countries (Italy, Austria, Germany, Ireland, Spain, Switzerland, and the UK). This partnership includes academic institutions, research centres, small and medium-sized enterprises and industry organisations, united in the aim of contributing to the advancement of knowledge and applications in the field of chronic wound healing.

OUR PARTNERS

Universities:

Research Centres:

SMEs:

Charities:

Download the press release in English at this link.

Download the press release in Italian at this link.

EU CORE Consulting srl
Italy

EUCORE is a small to medium-sized enterprise specialised in consultancy services for a diverse client base, including universities, research institutions, private companies, public administrations, and non-profit organisations, both in Italy and internationally. The company supports clients interested in participating in research, innovation, and cooperation initiatives funded by the European Union, as well as by national and international programmes. EUCORE’s expertise covers the entire lifecycle of project participation, offering tailored services in project design, partner identification, administrative and financial management, and reporting, particularly in relation to Horizon Europe and similar funding frameworks.

In INJECTHEAL, EUCORE is responsible for key activities, including leading the project’s dissemination and communication activities, and preparing and periodically updating the Data Management Plan and the Exploitation Plan.

Visit website

EU CORE Consulting srl
Italy

EUCORE is a small to medium-sized enterprise specialised in consultancy services for a diverse client base, including universities, research institutions, private companies, public administrations, and non-profit organisations, both in Italy and internationally. The company supports clients interested in participating in research, innovation, and cooperation initiatives funded by the European Union, as well as by national and international programmes. EUCORE’s expertise covers the entire lifecycle of project participation, offering tailored services in project design, partner identification, administrative and financial management, and reporting, particularly in relation to Horizon Europe and similar funding frameworks.

In INJECTHEAL, EUCORE is responsible for key activities, including leading the project’s dissemination and communication activities, and preparing and periodically updating the Data Management Plan and the Exploitation Plan.

Visit website

Cooming soon...